<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> may develop in connection with rare, <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic diseases</z:e> or after exceptional, environmental exposures </plain></SENT>
<SENT sid="1" pm="."><plain>Most commonly, however, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> results from an unhappy coincidence of <z:mpath ids='MPATH_458'>normal</z:mpath>, genetic factors and ordinary, environmental conditions </plain></SENT>
<SENT sid="2" pm="."><plain>Oncogenes are <z:mpath ids='MPATH_458'>normal</z:mpath> growth genes </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-oncogenes are <z:mpath ids='MPATH_458'>normal</z:mpath> regulatory genes which control growth genes </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> may result from changes (mutations) in an oncogene (such as in the Philadelphia chromosome), or from the lack of control of <z:mpath ids='MPATH_458'>normal</z:mpath> oncogenes </plain></SENT>
<SENT sid="5" pm="."><plain>The latter may be due to loss of function of a suppressor gene (mutation in an anti-oncogene, such as in <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>) or through a change in the position of an oncogene (such as in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and in certain <z:hpo ids='HP_0001909'>leukemias</z:hpo>) </plain></SENT>
</text></document>